A carregar...
外周血游离DNA的动态变化预测TKI治疗EGFR突变肺腺癌患者的疗效
BACKGROUND AND OBJECTIVE: The tyrosine kinase inhibitors (TKI) treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation may have a positive effect, but most patients may develop drug resistance, therefore, the detection of the developing time in drug resi...
Na minha lista:
| Publicado no: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
中国肺癌杂志编辑部
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6754570/ https://ncbi.nlm.nih.gov/pubmed/31526460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2019.09.03 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|